270
Participants
Start Date
October 18, 2023
Primary Completion Date
January 31, 2027
Study Completion Date
April 30, 2027
Darlifarnib
Oral administration
Cabozantinib
Oral administration
Adagrasib
Oral administration
RECRUITING
Fondazione Piemonte per l'Oncologia - IRCCs Candiolo, Candiolo
RECRUITING
UPMC Hillman Cancer Center, Pittsburgh
RECRUITING
Camplus Humanitas University, Rozzano
RECRUITING
Hospital HM Sanchinarro START Madrid-CIOCC, Madrid
RECRUITING
Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse
RECRUITING
Mayo Clinic Comprehensive Cancer Center, Jacksonville
RECRUITING
Florida Cancer Specialists, Sarasota
RECRUITING
AdventHealth Celebration, Celebration
RECRUITING
AOU Verona - Centro Ricerche Cliniche di Verona, Verona
RECRUITING
SCRI - Oncology Partners, Nashville
RECRUITING
Azienda Ospedaliera Universitaria Policlinico Sant'Orsola Malpighi IRCCS, Bologna
RECRUITING
Hospital Universitario Virgen del Rocío, Seville
RECRUITING
Henry Ford Health System, Detroit
RECRUITING
University of Iowa Hospitals & Clinics, Iowa City
RECRUITING
University of Wisconsin (Carbone Cancer Center), Madison
RECRUITING
Mayo Clinic Comprehensive Cancer Center, Rochester
RECRUITING
Washington University School of Medicine, St Louis
RECRUITING
OU Stephenson Cancer Center, Oklahoma City
RECRUITING
Oncologie médicale - Pitié-Salpêtrière, Paris
RECRUITING
Hopital Européen Georges Pompidou, Paris
RECRUITING
UT Southwestern Simmons Cancer Center, Dallas
RECRUITING
MD Anderson Cancer Center, Houston
RECRUITING
Istituto Nazionale Tumori IRCCS, Napoli
RECRUITING
Sarah Cannon Research Institute at HealthONE, Denver
RECRUITING
Mayo Clinic Comprehensive Cancer Center, Phoenix
RECRUITING
University of Southern California, Los Angeles
RECRUITING
Cedars-Sinai Medical Center, Los Angeles
RECRUITING
UCLA Department of Medicine, Los Angeles
RECRUITING
Dana-Farber Cancer Institute, Boston
RECRUITING
Rutgers Cancer Institute of New Jersey, New Brunswick
RECRUITING
Hospital Universitari Vall d'Hebron, Barcelona
RECRUITING
Hospital de la Santa Creu i de Sant Pau, Barcelona
Lead Sponsor
Collaborators (1)
Mirati Therapeutics Inc.
INDUSTRY
Kura Oncology, Inc.
INDUSTRY